Doxapram

Drug Profile

Doxapram

Alternative Names: Dopram

Latest Information Update: 07 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Unknown
  • Developer Kissei Pharmaceutical; Unknown
  • Class Morpholines; Pyrrolidinones; Respiratory stimulants; Small molecules
  • Mechanism of Action Central nervous system stimulants; Chemoreceptor cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Apnoea; Respiratory insufficiency

Most Recent Events

  • 20 Mar 2015 Registered for Apnoea (In neonates) in Japan (IV)
  • 20 May 2014 Preregistration for Apnoea (in neonates) in Japan (IV)
  • 01 Jan 1995 Launched for Respiratory insufficiency (in adults) in USA, Europe, China and India (IV) prior to 1995
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top